MC1690A1 - Nouveaux composes,leur procede de preparation et composition pharmaceutique les contenant - Google Patents

Nouveaux composes,leur procede de preparation et composition pharmaceutique les contenant

Info

Publication number
MC1690A1
MC1690A1 MC851781A MC1782A MC1690A1 MC 1690 A1 MC1690 A1 MC 1690A1 MC 851781 A MC851781 A MC 851781A MC 1782 A MC1782 A MC 1782A MC 1690 A1 MC1690 A1 MC 1690A1
Authority
MC
Monaco
Prior art keywords
compound
formula
configuration
mixture
och
Prior art date
Application number
MC851781A
Other languages
English (en)
French (fr)
Inventor
Roy-Archibald Swaringen
Hassan-Ali El-Sayad
David Arthur Yeowell
John-Joseph Savarese
Original Assignee
Wellcome Found
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found, Gen Hospital Corp filed Critical Wellcome Found
Publication of MC1690A1 publication Critical patent/MC1690A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals
    • C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Jib Cranes (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Fats And Perfumes (AREA)
  • Cosmetics (AREA)
MC851781A 1984-07-18 1985-07-17 Nouveaux composes,leur procede de preparation et composition pharmaceutique les contenant MC1690A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848418303A GB8418303D0 (en) 1984-07-18 1984-07-18 Compounds

Publications (1)

Publication Number Publication Date
MC1690A1 true MC1690A1 (fr) 1986-07-18

Family

ID=10564058

Family Applications (1)

Application Number Title Priority Date Filing Date
MC851781A MC1690A1 (fr) 1984-07-18 1985-07-17 Nouveaux composes,leur procede de preparation et composition pharmaceutique les contenant

Country Status (30)

Country Link
US (1) US4761418A (de)
EP (1) EP0181055B1 (de)
JP (1) JPH0662568B2 (de)
AT (1) ATE60759T1 (de)
AU (1) AU574481B2 (de)
BG (1) BG60411B2 (de)
CA (1) CA1273341A (de)
CY (1) CY1687A (de)
DD (1) DD235638A5 (de)
DE (2) DE19675039I2 (de)
DK (1) DK168093B1 (de)
ES (1) ES8609260A1 (de)
FI (1) FI85019C (de)
GB (1) GB8418303D0 (de)
GE (1) GEP19960468B (de)
HK (1) HK47593A (de)
HU (1) HU193996B (de)
IE (1) IE58138B1 (de)
IL (1) IL75833A (de)
LT (1) LT2078B (de)
LU (1) LU88801I2 (de)
LV (1) LV5483A3 (de)
MC (1) MC1690A1 (de)
MX (1) MX9203667A (de)
NL (1) NL940023I2 (de)
NZ (1) NZ212766A (de)
PL (1) PL146066B1 (de)
SG (1) SG3493G (de)
SU (1) SU1468414A3 (de)
ZA (1) ZA855407B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453510A (en) * 1990-07-13 1995-09-26 Burroughs Wellcome Co. Neuromuscular blocking agents
US5240939A (en) * 1991-10-31 1993-08-31 Anaquest, Inc. Nitrogen bridge tetrahydroisoquinolines
US5510355A (en) * 1994-09-06 1996-04-23 Bencherif; Merouane Depolarizing skeletal muscle relaxants
BR9808422B1 (pt) * 1997-03-25 2010-08-24 composto, composiÇço farmacÊutica, uso de um composto, e, processo para a preparaÇço de um composto.
GB0204087D0 (en) * 2002-02-21 2002-04-10 Legislator 1563 Ltd Di-ester derivatives as short acting neuromuscular blockers
EP1684753A2 (de) * 2003-10-28 2006-08-02 Cornell Research Foundation, Inc. Neuromuskuläre blockiermittel und ihre antagonisten
US7872137B2 (en) * 2006-06-20 2011-01-18 Farmabios S.P.A. Process for the preparation of mivacurium chloride
ATE554769T1 (de) * 2006-12-06 2012-05-15 Cornell Res Foundation Inc Neuromuskuläre blocker mit mittlerer dauer und antagonisten advon
WO2008107887A2 (en) * 2007-03-08 2008-09-12 Chemagis Ltd. (1r,1'r)-atracurium salts separation process
WO2008117271A1 (en) * 2007-03-26 2008-10-02 Chemagis Ltd. (1r,1'r)-atracurium salts separation process
WO2008132748A1 (en) * 2007-05-01 2008-11-06 Chemagis Ltd. Process for producing cisatracurium compounds and associated intermediates
US8357807B2 (en) * 2007-05-01 2013-01-22 Chemagis Ltd. Isoquinolinium compounds useful in the preparation of cisatracurium and associated intermediates
US8357805B2 (en) * 2007-06-18 2013-01-22 Chemagis Ltd. (1R,1′R)-atracurium salts separation process
CA2692636A1 (en) * 2007-07-09 2009-01-15 Chemagis Ltd. Process for producing cisatracurium and associated intermediates
CA2702535A1 (en) * 2007-10-29 2009-05-07 Chemagis Ltd. Novel r,r'-atracurium salts
ITMI20080319A1 (it) 2008-02-28 2009-08-29 Recordati Chem Pharm Processo per la risoluzione di derivati isochinolinici
BRPI0907656A2 (pt) * 2008-05-01 2019-08-27 Chemagis Ltd composto para testar a pureza de cisatracúrio, método para testar a pureza de uma amostra de besilato de cisatracúrio, uso de um composto para testar a pureza de cisatracúrio e processo para preparar compostos para testar a pureza de cisatracúrio
US8592451B2 (en) 2009-03-17 2013-11-26 Cornell University Reversible nondepolarizing neuromuscular blockade agents and methods for their use
US9220700B2 (en) 2009-08-19 2015-12-29 Cornell University Cysteine for physiological injection
WO2013021398A2 (en) * 2011-08-05 2013-02-14 Sequent Scientific Limited A process for preparation of mivacurium chloride
JP6236077B2 (ja) 2012-06-29 2017-11-22 コーネル・ユニバーシティーＣｏｒｎｅｌｌ Ｕｎｉｖｅｒｓｉｔｙ 持続時間が超短期、短期、または中期の非対称性逆転可能神経筋遮断物質
CN103373959A (zh) * 2013-06-14 2013-10-30 安徽省先锋制药有限公司 顺式苄基异喹啉类化合物的制备方法及其用途
CN107778237A (zh) * 2016-08-26 2018-03-09 四川科瑞德制药股份有限公司 一种神经肌肉阻滞剂中间体的新晶型及其制备方法和用途
CN107782821B (zh) * 2016-08-26 2021-11-09 四川科瑞德制药股份有限公司 一种神经肌肉阻滞剂的分析方法
CN108938573B (zh) * 2017-05-26 2021-08-10 四川科瑞德制药股份有限公司 一种神经肌肉阻滞剂组合物及其制备方法和用途
CN108503564A (zh) * 2017-09-30 2018-09-07 武汉嘉诺康医药技术有限公司 一种米库氯铵中间体及利用该中间体合成米库氯铵的方法
CN110361472B (zh) * 2019-07-29 2022-04-29 武汉嘉诺康医药技术有限公司 一种米库氯铵中间体miv-g异构体的hplc检测方法
CN111004179B (zh) * 2019-11-11 2021-03-09 武汉大安制药有限公司 一种5’-甲氧基劳丹素的拆分方法
CN116410078B (zh) * 2021-12-29 2026-04-03 苏州特瑞药业股份有限公司 一种制备(e)-辛-4-烯-1,8-二酸的方法
WO2025140288A1 (zh) * 2023-12-25 2025-07-03 上海森辉医药有限公司 一种四氢异喹啉及其药物用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB863717A (en) * 1958-07-03 1961-03-22 Allen & Hanburys Ltd Tetrahydropapaverine derivatives and their preparation
US3004031A (en) * 1958-07-03 1961-10-10 Allen & Hauburys Ltd Diquaternary salts of papaverino esters
AU506657B2 (en) * 1975-12-10 1980-01-17 Wellcome Foundation Limited, The Isoquinoline derivatives
SU862820A3 (ru) * 1977-08-01 1981-09-07 Дзе Массачусетс Дженерал Хоспитал (Фирма) Способ получени производных изохинолини
US4192877A (en) * 1977-08-01 1980-03-11 Massachusetts General Hospital Neuromuscular blocking agents
CA1125287A (en) * 1978-07-21 1982-06-08 John J. Savarese Bis isoquinolinium compositions and methods of use
US4235906A (en) * 1978-07-21 1980-11-25 Massachusetts General Hospital Bis-isoquinolinium compounds, compositions and methods of use
US4491665A (en) * 1979-10-19 1985-01-01 Burroughs Wellcome Co. Method of preparing isomers of bis isoquinolinium compounds
CA1153380A (en) * 1979-10-19 1983-09-06 Hassan A. El-Sayad Neuromuscular blocking tetrahydroisoquinolinium salts
EP0054309B1 (de) * 1980-12-17 1984-08-22 The Wellcome Foundation Limited Neuromuskuläre Blocker mit langer Wirkung, pharmazeutische Zubereitungen, die sie enthalten, und Verfahren zu ihrer Herstellung
JPS5899465A (ja) * 1981-11-23 1983-06-13 ザ・ウエルカム・フアウンデ−シヨン・リミテツド イソキノリン誘導体

Also Published As

Publication number Publication date
FI852807L (fi) 1986-01-19
HK47593A (en) 1993-05-21
US4761418A (en) 1988-08-02
HUT40626A (en) 1987-01-28
BG60411B2 (bg) 1995-02-28
LT2078B (lt) 1993-06-15
LV5483A3 (lv) 1994-03-10
PL146066B1 (en) 1988-12-31
AU574481B2 (en) 1988-07-07
HU193996B (en) 1987-12-28
FI852807A0 (fi) 1985-07-17
FI85019C (fi) 1992-02-25
NZ212766A (en) 1988-03-30
GB8418303D0 (en) 1984-08-22
CY1687A (en) 1993-10-10
IE58138B1 (en) 1993-07-14
SU1468414A3 (ru) 1989-03-23
JPS6187666A (ja) 1986-05-06
PL254571A1 (en) 1986-07-15
MX9203667A (es) 1992-07-31
JPH0662568B2 (ja) 1994-08-17
ATE60759T1 (de) 1991-02-15
ES8609260A1 (es) 1986-09-01
GEP19960468B (en) 1996-08-29
AU4510885A (en) 1986-01-23
NL940023I1 (nl) 1995-01-02
DK168093B1 (da) 1994-02-07
DK324985D0 (da) 1985-07-17
DD235638A5 (de) 1986-05-14
NL940023I2 (nl) 1998-06-02
CA1273341A (en) 1990-08-28
ES545319A0 (es) 1986-09-01
IL75833A (en) 1988-11-30
EP0181055A1 (de) 1986-05-14
ZA855407B (en) 1986-04-30
IE851791L (en) 1986-01-18
DK324985A (da) 1986-01-19
EP0181055B1 (de) 1991-02-06
IL75833A0 (en) 1985-11-29
SG3493G (en) 1993-03-12
LU88801I2 (fr) 1996-11-05
FI85019B (fi) 1991-11-15
DE3581699D1 (de) 1991-03-14
DE19675039I2 (de) 2003-01-09

Similar Documents

Publication Publication Date Title
MC1690A1 (fr) Nouveaux composes,leur procede de preparation et composition pharmaceutique les contenant
EP0040591B1 (de) Pyridoxin-Derivate, Verfahren zu ihrer Herstellung und ihre therapeutische Verwendung
JP2002503220A (ja) 超短時間作用性神経筋遮断薬としての置換イソキノリン類
EP0296975A1 (de) 2,2-Dimethyl-3-chromanol-Derivate, Verfahren zur Herstellung und diese enthaltende pharmazeutische Zusammenstellungen
EP0312432B1 (de) 2,2-Dimethylchromenderivate, Verfahren zur Herstellung und diese enthaltende pharmazeutische Zusammenstellungen
CH683427A5 (fr) Composé d'isoquinoléine comme agents de blocage neuromusculaire.
JP2001514632A (ja) 新規ヘテロサイクリック化合物
EP0148167A2 (de) Quinolinderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel
FR3107897A1 (fr) Dérivés de nicotinamide mononucléotides
EP0133176B1 (de) Pharmazeutische oder veterinäre Zubereitungen zur Behandlung von ischemischen Herzstörungen
EP0001021B1 (de) Derivate pentacyclischer Alkaloide, Verfahren zu deren Herstellung, Anwendung für die Synthese von Produkten der Eburnamoningruppe und pharmazeutische Zusammensetzungen
FR2510575A1 (fr) Nouveaux composes bicycliques, leur procede de preparation et composition pharmaceutique les renfermant
FR2610932A1 (fr) Nouvel acide piperazinecarboxylique, sa preparation et son utilisation comme medicament
KR880001009B1 (ko) 디하이드로리세르그산 에스테르 및 그의 제조방법
EP0079411B1 (de) Indoloquinolizinderivate, Verfahren zu ihrer Herstellung und ihre therapeutische Anwendung
FR2478639A1 (fr) Nouveaux derives de l'indolizino (8,7-b) indole et intermediaires, leur procede de preparation et leur utilisation en therapeutique
EP0103500B1 (de) Phenethyl-1-alpha-phenyl-piperidin-3-propannitril-Derivate, ihre Herstellung und therapeutische Verwendung
BE883523A (fr) Nouveaux derives de diphenyl-propylamino-pyridine a utiliser comme medicaments
KR0148755B1 (ko) 신규 테트라하이드로이소퀴놀린계 화합물 및 그의 염
FR2465723A1 (fr) Nouvelles diphenylpropylamino-pyridines utilisables comme medicaments
NZ199008A (en) 2,3,3a,4,5,6-hexahydro-ih-indolo(3,2,1-de)(1,5)-naphthyridines
EP0347733A1 (de) Optisch aktive Hydantoin-Derivate
JPH02135A (ja) 多還式化合物とこれを含有する医薬組成物
WO2008125658A1 (fr) Derives de 4,5,11,11a-tetrahydro-1h,6h-oxazolo[3',4':1,6]pyrido[3,4-b]indol-3-one et leur utilisation en therapeutique
BE831654A (fr) Nouveaux derives de quinazoline et medicament les contenant

Legal Events

Date Code Title Description
YP Annual fee paid